Digene® HPV Test: Only High-Risk HPV Test Approved by the FDA
The Digene® HPV Test is the only such test approved by the FDA that uses advanced molecular technology to detect the DNA (genetic material) of 13 high-risk types of HPV (the virus shown to actually cause virtually all cases of cervical cancer.)
Approved by the FDA in 2003 for cervical cancer screening in conjunction with a Pap, in women age 30 and older - Digene® HPV Test – is based on proprietary “Hybrid Capture” technology, which combines two innovations from the rapidly evolving field of life sciences – DNA/RNA probes and monoclonal antibodies – to allow rapid, standardized gene testing in virtually any laboratory setting.
Sounds great.
I only have one question: Do most insurance providers in the U.S. cover this HPV test? ( Because I am not based in the U.S, and where I am it probably is too expensive for normal women to afford.)
Greater if they do. Don’t you think?
No offense to the makers or PR people of the Digene® HPV Test, I am just saying that novel tests/screening procedure should be easily accessible to anybody.
Or maybe heads of States should have tests like this subsidized (if not free) to all women?
If Merck can lobby for the mandatory cervical cancer vaccination, why not mandate the cervical cancer screening test (if not already)?
(Is the Gardasil® mandate already reversed?)
Tags: cervical-cancer, cervical-cancer-screening, Digene®-HPV-Test, hpv, HPV-testRelated Stories
POSTED IN: on cancer diagnostics, on cervical cancer
0 opinions for Digene® HPV Test: Only High-Risk HPV Test Approved by the FDA
No one has left a comment yet. You know what this means, right? You could be first!
Have an opinion? Leave a comment: